AXIAL VITA AS
Operating
Salg og utvikling av biomedisinske produkter og tjeneste,
konsulentvirksomhet knyttet til bioteknologi og kosttilskudd, samt
virksomhet som naturlig faller innunder dette. Formålet kan fremmes
ved deltagelse i eller samarbeid med andre foretak i inn- og utland.
Salg og utvikling av biomedisinske produkter og tjeneste,
konsulentvirksomhet knyttet til bioteknologi og kosttilskudd.
Organization
- CEO
- ME
- Chairman of the board
- ME
- Years since formation
- 11 years
- since Sep 27, 2014
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 100
- 1 share class
- Total number of shareholders
- 2
- 1 company, 1 person
Financials
- Total operating income 2024
- 153,651
- NOK
- Annual total result 2024
- 15,679
- NOK
- Total equity 2024
- 145,545
- NOK
Last update: Sep 9, 2025
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
ME | Managing Director/CEO | 60 % directly |
Board
| Name | Role | Shares |
|---|---|---|
ME | Chairman | 60 % directly |
| Board Member | 40 % indirectly |
Others
| Name | Role | Shares |
|---|---|---|
| Accountant | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
ME | Managing Director/CEO, Chairman | 60 % directly |
| Board Member | 40 % indirectly |
Last update: Apr 13, 2023
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
ME | Ordinary shares | 60 | 60 % |
| Ordinary shares | 40 | 40 % |
Last update: Jun 2, 2025
Financials
in NOK
Summary
| Year | 2024 | 2023 | 2022 |
|---|---|---|---|
Total operating income | 153,651 | 166,266 | 197,073 |
Annual Total Result | 15,679 | 43,026 | 21,252 |
Total assets | 263,826 | 343,293 | 267,819 |
Total liabilities | 118,281 | 171,427 | 90,980 |
Total equity | 145,545 | 171,866 | 176,840 |
P&L
| Year | 2024 | 2023 | 2022 |
|---|---|---|---|
Total operating income | 153,651 | 166,266 | 197,073 |
Total operating costs | 134,243 | 111,091 | 170,451 |
Operating result | 19,408 | 55,175 | 26,622 |
Financial income/costs | 714 | 28 | 631 |
Profit before tax | 20,122 | 55,203 | 27,254 |
Total tax & extraordinary income/cost | 4,443 | 12,177 | 6,002 |
Annual Total Result | 15,679 | 43,026 | 21,252 |
Balance overview
| Year | 2024 | 2023 | 2022 |
|---|---|---|---|
Total fixed assets | 0 | 0 | 0 |
Total current assets | 263,826 | 343,293 | 267,819 |
Total assets | 263,826 | 343,293 | 267,819 |
Short term debt | 118,281 | 171,427 | 90,976 |
Long term debt | 0 | 0 | 4 |
Total liabilities | 118,281 | 171,427 | 90,980 |
Contributed capital | 30,000 | 30,000 | 30,000 |
Retained earnings | 115,545 | 141,866 | 146,840 |
Total equity | 145,545 | 171,866 | 176,840 |
Total equity and liabilities | 263,826 | 343,293 | 267,819 |
Classification
21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises